Concomitant inhaled corticosteroid use and the risk of pneumonia in COPD: a matched-subgroup post hoc analysis of the UPLIFT® trial.

No Thumbnail Available
Authors
Tashkin, D. P. [et al]
Halpin, David M
Journal
Respiratory research
Type
Journal Article
Publisher
BioMed Central
Rights
Archived with thanks to Respiratory research
Use of inhaled corticosteroids (ICS) increases the risk of pneumonia in chronic obstructive pulmonary disease (COPD), but the magnitude of risk with different ICS remains unclear.
Citation
Concomitant inhaled corticosteroid use and the risk of pneumonia in COPD: a matched-subgroup post hoc analysis of the UPLIFT® trial. 2018, 19 (1):196 Respir. Res.
Note
This article is freely available online via Open Access.